Australian cannabis company, Creso Pharma’s stocks have fallen due to its corporate advisory firm, Sydney-based EverBlu being under an ASIC investigation.
Australian cannabis company, Creso Pharma’s stocks have fallen due to its corporate advisory firm, Sydney-based EverBlu being under an ASIC investigation.